Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

Merck KGaA, Pfizer’s Bavencio stumbles in head and neck cancer

Checkpoint inhibitor unlikely to improve progression-free survival

- PMLiVE

NHS England will make PrEP for HIV available in April

Will be made available to patients at risk of contracting infection

- PMLiVE

Did Trump offer CureVac $1bn for COVID-19 vaccine rights?

Media reports claim Trump administration tried to secure exclusive rights

Great expectations: the urgent need for common purpose in Alzheimer’s disease

By Andrew Harrison

Don’t just hope: COPE

Tips to improve reach, engagement and ROI

Bedrock Healthcare Communications

- PMLiVE

AstraZeneca taps internal candidate to become UK president

Tom Keith-Roach has worked at the company for 17 years

- PMLiVE

Lilly and AbCellera partner on antibody therapies for COVID-19

Latest companies to join the fight against the novel coronavirus

- PMLiVE

FDA green lights study of phage-based drug for resistant infections

Possible alternative to conventional antibiotics

Roche Basel Switzerland

FDA okays Roche’s COVID-19 diagnostic test

Increases capacity for testing as coronavirus cases grow

- PMLiVE

UK officially moves into ‘delay’ phase of coronavirus plan

New measures includes broader self-isolation advice

- PMLiVE

EU grants approval for Venclyxto/Gazyvaro combo in CLL

Chemotherapy-free option for previously-untreated patients

- PMLiVE

Bringing the trial to the patient

By Gretchen Goller

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links